Effects of continuous renal replacement therapy on renal inflammatory cytokines during extracorporeal membrane oxygenation in a porcine model

Journal of Cardiothoracic Surgery

Volumn 8, Issue 1, 2013, Pages

  Yimin, Hu ^a   Wenkui, Yu ^a   Jialiang, Shi ^a   Qiyi, Chen ^a   Juanhong, Shen ^a   Zhiliang, Lin ^a   Changsheng, He ^a   Ning, Li ^a   Jieshou, Li ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Continuous renal replacement therapies; Extracorporeal membrane oxygenation; Renal inflammatory cytokines

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY INJURY; ADVERSE EFFECTS; ANIMAL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACORPOREAL OXYGENATION; KIDNEY; METABOLISM; PATHOLOGY; PIG; PROCEDURES; RENAL REPLACEMENT THERAPY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACUTE KIDNEY INJURY; ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACORPOREAL MEMBRANE OXYGENATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; KIDNEY; RENAL REPLACEMENT THERAPY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876792169     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-8-113     Document Type: Article

References (17)

1. Davies A, Jones D, Bailey M. Extracorporeal membrane oxygenation for 2009 influenza a(H1N1) acute respiratory distress syndrome[J]. JAMA 2009, 302:1888-1895.
2. Kumar A, Zarychanski R, Pinto R. Critically ill patients with 2009 influenza a(H1N1) infection in canada[J]. JAMA 2009, 302:1872-1879. 10.1001/jama.2009.1496, 19822627.
3. Chalwin RP, Moran JL, Graham PL. The role of extracorporeal membrane oxygenation for treatment of the adult respiratory distress syndrome: Review and quantitative analysis. Anaesth[J] Intensive Care 2008, 36:152-161.
4. Doll N, Kiaii B, Borger M. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock[J]. Ann Thorac Surg 2004, 77:151-157. 10.1016/S0003-4975(03)01329-8, 14726052.
5. Smedira NG, Moazami N, Golding CM. Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years[J]. J Thorac Cardiovasc Surg 2001, 122:92-102. 10.1067/mtc.2001.114351, 11436041.
6. Conrad SA, Rycus PT, Dalton H. Extracorporeal life support registry report 2004[J]. ASAIO J 2005, 51:4-10. 10.1097/01.MAT.0000151922.67540.E9, 15745126.
7. Sell LL, Cullen ML, Whittlesey GC. Experience with renal-failure during extracorporeal membrane oxygenation treatment with continuous hemofiltration[J]. J Pediatr Surg 1987, 2:600-602.
8. Gbadegesin R, Zhao S, Charpie J. Significance of hemolysis on extracorporeal life support after cardiac surgery in children[J]. Pediatr Nephrol 2009, 24:589-595. 10.1007/s00467-008-1047-z, 19002722.
9. Kelly RE, Phillips JD, Foglia RP. Pulmonary edema and fluid mobilization as determinants of the duration of ecmo support[J]. J Pediatr Surg 1991, 26:1016-1022. 10.1016/0022-3468(91)90665-G, 1941476.
10. Van Bommel E, Bouvy ND, So KL. A cute dialytic support for the critically ill: intermittent hemodialysis versus continuous arteriovenous hemodiafilltration[J]. Am J Nephrol 1995, 15:192. 10.1159/000168832, 7618643.
11. Leblanc M, Garred LJ, Cardinal J. Catabolism in critical illness: estimation from urea nitrogen appearance and creatinine production during continuous renal rep lacement therapy[J]. Am J Kidney Dis 1998, 32:444. 10.1053/ajkd.1998.v32.pm9740161, 9740161.
12. Lonnemann G, Bechstein M, Linnenweber S. Tumornecrosis factor alpha during continuous highflux hemodialysis in sepsis with acute renal failure[J]. Kidney Int Suppl 1999, 72:S84.
13. Peng Y, Yuan Z, Li H. Removal of inflammatory cytokines and endotoxin by venovenous continuous renal replacement therapy for burned patients with sepsis[J]. Burns 2005, 31:623. 10.1016/j.burns.2005.02.004, 15975721.
14. Beckmann A, Benk C, Beyersdorf F. Position article for the use of extracorporeal life support in adult patients[J]. Euro J of Cardio-th Surg 2011, 40:676-681.
15. Heilmann C, Trummer G, Berchtold-Herz M. Established markers of renal and hepatic failure are not appropriate to predict mortality in the acute stage before extracorporeal life support implantation[J]. Euro J Cardio-th Surg 2012, 1:1-7.
16. Alan MG, Stephen MW, Michael JG. Extracorporeal life support[J]. BMJ 2010, 341:982-986.
17. Britt ML, Joseph T, Ashish RK. Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of pre-formed stores in the intestine[J]. Lab Invest 2010, 90:128-139. 10.1038/labinvest.2009.119, 2799549, 19901912.